PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink brain tumors
Disease control Not yet recruitingThis study tests whether adding the targeted drug orelabrutinib to standard chemotherapy improves outcomes for people newly diagnosed with primary central nervous system lymphoma (a rare brain cancer). About 215 adults aged 18-75 will be randomly assigned to one of three treatmen…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New model aims to predict kidney risk from chemo drug
Knowledge-focused Not yet recruitingThis study looks at 50 adults with primary central nervous system lymphoma who are receiving high-dose methotrexate. The goal is to see if measuring the drug early in the blood can predict later kidney problems, so doctors can act faster to prevent harm. It is an observational st…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC